Targeting PI3K/Akt signal transduction for cancer therapy
2021 · Signal Transduction and Targeted Therapy · 1,665 citations
https://doi.org/10.1038/s41392-021-00828-5
W
Wen Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
246
Papers
6.8K
Citations
37
h-index
99
i10-index
Wen Xu is an academic researcher from Qingdao University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Cancer-related Molecular Pathways. The author has an h-index of 37, co-authored 210 publications.
ORCID: 0009-0007-0759-5974Papers by this author
worksClinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study
2018 · European Urology · 120 citations
https://doi.org/10.1016/j.eururo.2018.01.010
LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway
2019 · Journal of Experimental & Clinical Cancer Research · 120 citations
https://doi.org/10.1186/s13046-019-1150-y
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
2017 · British Journal of Cancer · 100 citations
https://doi.org/10.1038/bjc.2017.142
Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression
2017 · Nature Communications · 91 citations
https://doi.org/10.1038/ncomms14399
Quantitative parameters of CT texture analysis as potential markers for early prediction of spontaneous intracranial hemorrhage enlargement
2018 · European Radiology · 67 citations
https://doi.org/10.1007/s00330-018-5364-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat